Neutralizing TGF-β1 antibody infusion in neonatal rat delays in vivo glomerular capillary formation

Kidney International

Volumn 56, Issue 4, 1999, Pages 1334-1348

  Liu, Ailian ^a   Dardik, Alan ^a   Ballerimann, Barbara J ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Differentiation; Fenestrae; Glomerular endothelium; Rat kidney

Indexed keywords

NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; DIAGNOSTIC AGENT; ENDOTHELIAL CELL GROWTH FACTOR; IMMUNOGLOBULIN G; LYMPHOKINE; RADIOACTIVE IODINE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN A; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; CAPILLARY PROLIFERATION; CELL MATURATION; CELL ULTRASTRUCTURE; CONFERENCE PAPER; ENDOTHELIUM CELL; FEMALE; GLOMERULUS CAPILLARY; IMMUNOHISTOCHEMISTRY; KIDNEY DEVELOPMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; BINDING COMPETITION; BIOSYNTHESIS; CAPILLARY; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; ELECTRON MICROSCOPY; GLOMERULUS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; MICROINJECTION; NEPHRON; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; SERODIAGNOSIS; SPRAGUE DAWLEY RAT; TIME; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; BINDING, COMPETITIVE; CAPILLARIES; CELL DIFFERENTIATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOGLOBULIN G; INJECTIONS, INTRA-ARTERIAL; IODINE RADIOISOTOPES; KIDNEY GLOMERULUS; LYMPHOKINES; MICROINJECTIONS; MICROSCOPY, ELECTRON; NEPHRONS; NEUTRALIZATION TESTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0032587571     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00661.x     Document Type: Conference Paper

References (46)

1. ROBERT B, Si JOHN PL, ABRAHAMSON DR. Direct visualization of renal vascular morphogenesis in flk1 heterozygous mutant mice. Am J Physiol 275:F164-F172, 1998
2. Liu A, BALLERMANN BJ. TGF-β type II receptor in rat renal vascular development. Localization to juxtaglomerular cells. Kidney Int 53:716-725, 1998
3. HYINK DP, ABRAHAMSON DR. Origin of the glomerular vasculature in the developing kidney. Semin Nephrol 15:300-314, 1995
4. HANAHAN D. Signaling vascular morphogenesis and maintenance. Science 277:48-50, 1997
5. TAKAHASHI T, HUYNH DOU, DANIEL TO. Renal microvascular assembly and repair. Power and promise of molecular definition. Kidney Int 53:826-835, 1998
6. SHALABY F, ROSSANT J, YAMAGUCHI TP, GERTSENSTEIN M, Wu XF, BREITMAN ML, SCHUH AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66, 1995
7. DUMONT DJ, GRADWOHL G, FONG GH, PURI MC, GERTSENSTEIN M,.AUERBACH A, BREITMAN ML. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909, 1994
8. BREIER G, ALBRECHT U, STERRER S, RISAU W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521-532, 1992
9. KITAMOTO Y, TOKUNAGA H, TOMITA K. Vascular endothelial growth factor is an essential molecule for mouse kidney development. Glomerulogenesis and nephrogenesis. J Clin Invest 99:2351-2357, 1997
10. BROWN LF, BERSE B, TOGNAZZI K, MANSEAU EJ, VAN DE WATER L, SENGER DR, DVORAK HF, ROSEN S. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42:1457-1461, 1992
11. SIMON M, GRONE HJ, JOHREN O, KULLMER J, PLATE KH, RISAU W, Fucus E. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250, 1995
12. ROBERTS WG, PALADE GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369-2379, 1995
13. ROBERTS WG, PALADE GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 57:765-772, 1997
14. ESSER S, WOLBURG K, WOLBURG H, BREIER G, KURZCHALIA T, RISAU W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Bio! 140:947-959, 1998
15. SATO TN, TOZAWA Y, DEUTSCH U, WOLBURG-BUCHHOLZ K, FuiiWARA Y, GENDRON-MAGUIRE M, GRIDLEY T, WOLBURG H, RISAU W, QIN Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74, 1995
16. SURI C, JONES PF, PATAN S, BARTUNKOVA S, MAISONPIERRE PC, DAVIS S, SATO TN, YANCOPOULOS GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180, 1996
17. WITZENBICHLER B, MAISONPIERRE PC, JONES P, YANCOPOULOS GD, ISNER JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinasc Tie2. J Biol Chem 273:18514-18521, 1998
18. MAISONPIERRE PC, SURI C, JONES PF, BARTUNKOVA S, WIEGAND SJ, RADZIEJEWSKI C, COMPTON D, McCLAIN J, ALDRICH TH, PAPADOPOULOS N, DALY TJ, DAVIS S, SATO TN, YANCOPOULOS GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997
19. VIKKULA M, BOON LM, CARRAWAY KL, CALVERT JT, DIAMONTI AJ, GOUMNEROV B, PASYK KA, MARCHUK DA, WARMAN ML, CANTLEY LC, MULLIKEN JB, OLSEN BR. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190, 1996
20. LOUGHNA S, HARDMAN P, LANDELS E, JUSSILA L, ALITALO K,WOOLF AS. A molecular and genetic analysis of renal glomerular capillary development. Angiogenesis 1:84-101, 1997
21. WANG HU, CHEN ZF, ANDERSON DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753, 1998
22. DANIEL TO, STEIN E, CERRETTI DP, ST JOHN PL, ROBERT B, ABRAHAMSON DR. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int 50(Suppl 57):S73-S81, 1996
23. ROBERTS AB, SPORN MB, ASSOIAN RK, SMITH JM, ROCHE NS, WAKEFIELD LM, HEINE UI, LIOTTA LA, FALANGA V, KEHRL JH, FAUCI AS. Transforming growth factor type beta. Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171, 1986
24. UEKI N, NAKAZATO M, OHKAWA T, IKEDA T, AMURO Y, HADA T, HIGASHINO K. Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis. Validity of neutralizing antibodies to block tumor growth. Biochim Biopliys Acta 1137:189-196, 1992
25. HEIMARK RL,TWARDZIK DR, SCHWARTZ SM. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233:1078-1080, 1986
26. FRANK S, HUBNER G, BREIER G, LONGAKER MT, GREENHALGH DG, WERNER S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607-12613, 1995
27. PERTOVAARA L, KAIPAINEN A, MUSTONEN T, ORPANA A, FERRARA N, SAKSELA O, ALITALO K. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269:6271-6274, 1994
28. MAORI JA, PRATT BM, TUCKER AM. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106:1375-1384, 1988
29. GAJDUSEK CM, Luo Z, MAYBERG MR. Basic fibroblast growth factor and transforming growth factor beta-1. Synergistic mediators of angiogenesis in vitro. J Cell Physiol 157:133-144, 1993
30. PEPPER MS, VASSALLI JD, ORCI L, MONTESANO R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 204:356-363, 1993
31. CHOI ME, BALLERMANN BJ. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors. J Biol Chem 270:21144-21150, 1995
32. DICKSON MC, MARTIN JS, COUSINS FM, KULKARNI AB, KARLSSON S, AKHURST RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845-1854, 1995
33. OSHIMA M, OSHIMA H, TAKETO MM. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179:297-302, 1996
34. PROETZEL G, PAWLOWSKI SA, WILES MV, YIN M, BOIVIN GP, HOWLES PN, DING J, FERGUSON MW, DOETSCHMAN T. Transforming growth factor-beta 3 is required for secondary palate fusion. Nature Genet 11:409-414, 1995
35. KAARTINEN V, VONCKEN JW, SHULER C, WARBURTON D, Bu D, HEISTERKAMP N, GROFFEN J. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nature Genet 11:415-421, 1995
36. SANFORD LP, ORMSBY I, GITTENBERGER-DE GROOT AC, SARIOLA H, FRIEDMAN R, BOIVIN GP, CARDELL EL, DOETSCHMAN T. TGFbeta2 knockout mice have multiple developmental defects that are nonoverlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670, 1997
37. MORELLO JP, PLAMONDON J, MEYRICK B, HOOVER R, O'CONNORMcCOUT MD. Transforming growth factor-beta receptor expression on endothelial cells. Heterogeneity of type III receptor expression. J Cell Physiol 165:201-211, 1995
38. McALLISTER KA, GROGG KM, JOHNSON DW, GALLIONE CJ, BALDWIN MA, JACKSON CE, HELMBOLD EA, MARKEL DS, McKINNON WC, MURRELL J, McCORMICK MK, PERICAK-VANCE MA, HEUTING P, OOSTRA B A, HAITJEMAT, WESTERMAN CJJ, PORTEOUS ME, GUTMACHER AE, LETARTE M, MARCHUK DA. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet 8:345-351,1994
39. SANKAR S, MAHOOTI-BROOKS N, CENTRELLA M, MCCARTHY TL, MAORI JA. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor beta 2. J Biol Chem 270:13567-13572, 1995
40. JOHNSON DW, BERG JN, BALDWIN MA, GALLIONE CJ, MARONDEL I. YOON SJ, STENZEL TT, SPEER M, PERICAK-VANCE MA, DIAMOND A, GUTTMACHER AE, JACKSON CE, ATTISANO L, KUCHERLAPATI R, PORTEOUS ME, MARCHUK DA. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature Genet 13:189-195, 1996
41. VAN WAARDE MAWH, VAN ASSEN AJ, KAMPINGA HH, KONINGS AWT, VUJASKOVIC Z. Quantification of transforming growth factor-β in biological materials using cells transfected with a plasminogen activator inhibitor-l promoter-luciferase construct. Anal Biochem 247:45-51, 1997
42. CHOI ME, LIU AL, BALLERMANN BJ. Differential expression of transforming growth factor-beta receptors in rat kidney development. Am J Physiol 42:F386-F395, 1997
43. JAKEMAN LB, WINERJ, BENNETT GL, ALTAR CA, FERRARA N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. / Clin Invest 89:244-253,1992
44. MANDRIOTA SJ, MENOUD PA, PEPPER MS. Transforming growth factor bl downregulates vascular endothelial growth factor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 271:11500-11505, 1996
45. KUZUYA M, KINSELLA JL. Reorganization of endothelial cord-like structures on basement membrane complex (Matrigel). Involvement of transforming growth factor beta l.J Cell Physiol 161:267-276, 1994
46. GAJDUSEK CM, CARBON S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol 139:570-579, 1989